<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Physiol.</journal-id>
<journal-title>Frontiers in Physiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Physiol.</abbrev-journal-title>
<issn pub-type="epub">1664-042X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1076327</article-id>
<article-id pub-id-type="doi">10.3389/fphys.2023.1076327</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Physiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Oxidative balance score reflects vascular endothelial function of Chinese community dwellers</article-title>
<alt-title alt-title-type="left-running-head">Liu et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphys.2023.1076327">10.3389/fphys.2023.1076327</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Jianhua</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>He</surname>
<given-names>Lingxiao</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1777673/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Aozhe</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2064497/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lv</surname>
<given-names>Yuanyuan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1533625/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>He</surname>
<given-names>Hui</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1770987/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Chenghao</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xiong</surname>
<given-names>Kaiyu</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Zhao</surname>
<given-names>Li</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/407967/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Exercise Physiology</institution>, <institution>Beijing Sport University</institution>, <addr-line>Beijing</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>College of Physical Education</institution>, <institution>WeiFang University</institution>, <addr-line>WeiFang</addr-line>, <addr-line>Shandong</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>School of Public Health</institution>, <institution>Xiamen University</institution>, <addr-line>Xiamen</addr-line>, <addr-line>Fujian</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/514641/overview">Claudio Molinari</ext-link>, University of Eastern Piedmont, Italy</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/68223/overview">Mallikarjuna Korivi</ext-link>, Zhejiang Normal University, China</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/361612/overview">Qing-Song Liu</ext-link>, Medical College of Wisconsin, United States</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Li Zhao, <email>zhaolispring@126.com</email>
</corresp>
<fn fn-type="equal" id="fn1">
<label>
<sup>&#x2020;</sup>
</label>
<p>These authors have contributed equally to this work and share first authorship</p>
</fn>
<fn fn-type="other">
<p>This article was submitted to Redox Physiology, a section of the journal Frontiers in Physiology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>17</day>
<month>04</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>14</volume>
<elocation-id>1076327</elocation-id>
<history>
<date date-type="received">
<day>21</day>
<month>10</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>27</day>
<month>03</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Liu, He, Wang, Lv, He, Wang, Xiong and Zhao.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Liu, He, Wang, Lv, He, Wang, Xiong and Zhao</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>
<bold>Background:</bold> The oxidative balance score (OBS) is a composite estimate of the overall pro- and antioxidant risk status in an individual. The aim of this study is to explore the association between the OBS and vascular endothelial function in Chinese community dwellers.</p>
<p>
<bold>Methods:</bold> In total, 339 community dwelling adults (aged 20&#x2013;75&#xa0;years) were recruited in this study. The overall OBS was calculated on the basis of 16 pro- and antioxidant factors related to diet (measured by fasting blood samples) and lifestyle (evaluated by questionnaires). The dietary OBS and lifestyle OBS were calculated on the basis of the corresponding components. Serum iso-prostaglandin F2&#x3b1; (FIP) was measured to evaluate the oxidative stress degree, and brachial artery blood flow-mediated dilation (FMD) was measured for vascular endothelial function. The FIP and FMD levels were dichotomized as &#x201c;low&#x201d; or &#x201c;high&#x201d; using the corresponding median values (low FIP, <italic>n</italic> &#x3d; 159; high FIP, <italic>n</italic> &#x3d; 180; low FMD, <italic>n</italic> &#x3d; 192; and high FMD, <italic>n</italic> &#x3d; 147). The components of the OBS were compared between the stratified FIP and FMD groups. Logistic regression was used to analyze the OBS associations with FIP and FMD.</p>
<p>
<bold>Results:</bold> The higher overall OBS and dietary OBS were associated with lower FIP (<italic>p</italic> &#x3c; 0.001), whereas the higher overall OBS (<italic>p</italic> &#x3c; 0.01) and dietary OBS (<italic>p</italic> &#x3c; 0.05) were associated with higher FMD. The lifestyle OBS was not associated with FIP and FMD (<italic>p</italic> &#x3e; 0.05). Except for the body mass index (BMI) and low physical activity, all other OBS components were significantly different between the low FIP and high FIP groups (<italic>p</italic> &#x3c; 0.05). Four diet-related antioxidants (&#x3b1;-carotene, zeaxanthin, &#x3b1;-tocopherol, and &#x3b3;-tocopherol) showed significant differences between the high and low FMD groups (<italic>p</italic> &#x3c; 0.05).</p>
<p>
<bold>Conclusion:</bold> The decreasing OBS level was associated with low endothelial function and high oxidative stress. The dietary OBS, rather than the lifestyle OBS, was more closely associated with endothelial function.</p>
</abstract>
<kwd-group>
<kwd>oxidative balance score</kwd>
<kwd>vascular endothelial function</kwd>
<kwd>lifestyle OBS</kwd>
<kwd>dietary OBS</kwd>
<kwd>Chinese community dwellers</kwd>
</kwd-group>
<contract-num rid="cn002">2017SYS008 2022YB012</contract-num>
<contract-sponsor id="cn001">National Key Research and Development Program of China<named-content content-type="fundref-id">10.13039/501100012166</named-content>
</contract-sponsor>
<contract-sponsor id="cn002">Chinese Universities Scientific Fund<named-content content-type="fundref-id">10.13039/501100005236</named-content>
</contract-sponsor>
</article-meta>
</front>
<body>
<sec id="s1">
<title>1 Introduction</title>
<p>Oxidative stress (OS) is a condition that occurs when there is an imbalance between the production of free radicals and defense of antioxidants, resulting in excessive accumulation of reactive oxygen species (ROS) and reactive nitrogen species (RNS) (<xref ref-type="bibr" rid="B38">Niki, 2018</xref>). It is reported that OS plays an important role in initiating and mediating chronic non-communicable pathophysiology diseases, such as cardiovascular disease (CVD), hypertension, and type 2 diabetes (<xref ref-type="bibr" rid="B50">Stanner et al., 2004</xref>). The presence of OS can alter protein structure and hinder enzymes such as the endothelial nitric oxide synthase (eNOs), thereby resulting in dysfunction and inability of the endothelium to release and respond to vasodilators (<xref ref-type="bibr" rid="B5">Cathcart, 2004</xref>; <xref ref-type="bibr" rid="B64">Yokoyama, 2004</xref>; <xref ref-type="bibr" rid="B2">Antelava et al., 2005</xref>). Although the pathophysiology of CVD is extremely complex and multifactorial, local injury to, or dysfunction of, endothelial cells appear to be an important factor in the initiation of atherosclerosis (<xref ref-type="bibr" rid="B9">Dokken, 2008</xref>). Besides, the mitochondrial respiratory chain, NADPH oxidase, an uncoupled endothelial nitric oxide (NO) synthase, and xanthine oxidase also produce ROS that causes elevated levels of OS in the vascular system of people with high risk factors (<xref ref-type="bibr" rid="B20">Griendling et al., 2021</xref>). An increased formation of ROS from all layers of the vascular wall may alter the vascular function and contribute to the development and progression of CVD (<xref ref-type="bibr" rid="B6">Cersosimo and DeFronzo, 2006</xref>). OS may be the earliest biological event in chronic CVD pathological cascade and is responsible for triggering all other pathologies, indicating that reducing OS may be a viable approach in disease treatment.</p>
<p>OS process is affected by environment, lifestyle, and diet. Cigarettes, ionizing radiation, environment pollution, medicine, iron, saturated fatty acid, and other prooxidants all boost the OS process. Fitting exercise and antioxidants, which include vitamin C, vitamin E, vitamin A, carotenoids, and selenium, all reduce the OS degree (<xref ref-type="bibr" rid="B58">Valko et al., 2007</xref>). Notably, although lab work has demonstrated that antioxidants can slowdown the progression of hypertension, further clinical evidence is still required (<xref ref-type="bibr" rid="B42">Pietta, 2000</xref>; <xref ref-type="bibr" rid="B41">Padayatty et al., 2003</xref>; <xref ref-type="bibr" rid="B49">Stahl and Sies, 2003</xref>), and clinical trials have failed to find any benefit of antioxidant supplements in hypertension treatment (<xref ref-type="bibr" rid="B21">Heart Protection Study Collaborative Group, 2002</xref>; <xref ref-type="bibr" rid="B46">Rodrigo et al., 2013</xref>) or cardiovascular disease prevention (<xref ref-type="bibr" rid="B65">Yusuf et al., 2000</xref>; <xref ref-type="bibr" rid="B7">Cort&#xe9;s-Jofr&#xe9; et al., 2020</xref>). Such an inconsistency between lab and clinical research implies that the impact of the body&#x2019;s oxidative status on the cardiovascular system is complex and not exclusively determined by antioxidant factors. In fact, the body&#x2019;s oxidative status is the result of interactions among multiple pro-/antioxidant factors. Therefore, studies on OS-related pathophysiology should combine information of both pro- and antioxidant factors, rather than a single factor. The oxidative balance score (OBS) is an approach that evaluates the overall oxidative status in the body <italic>via</italic> the combined status of pro- and antioxidants (<xref ref-type="bibr" rid="B62">Van Hoydonck et al., 2002</xref>). Previous studies have used 12&#x2013;14 pro- and antioxidant factors related to nutrients, lifestyle, body composition, and medical history for OBS calculation, with antioxidants contributing positively to the value and prooxidants contributing negatively to the value (<xref ref-type="bibr" rid="B30">Kong et al., 2015</xref>; <xref ref-type="bibr" rid="B39">Noruzi et al., 2021</xref>). The higher OBS has been associated with a lower risk of various non-communicable diseases and adverse outcomes, such as hypertension (<xref ref-type="bibr" rid="B1">Annor et al., 2015</xref>), colorectal adenoma (<xref ref-type="bibr" rid="B8">Dash et al., 2013</xref>), prostate cancer (<xref ref-type="bibr" rid="B31">Lakkur et al., 2014</xref>), chronic kidney disease, and all-cause mortality (<xref ref-type="bibr" rid="B22">Ilori et al., 2015</xref>; <xref ref-type="bibr" rid="B30">Kong et al., 2015</xref>). In the development of these disease conditions, OS-induced endothelial dysfunction, which is usually estimated by flow-mediated dilation (FMD) of the brachial artery (<xref ref-type="bibr" rid="B55">Thijssen et al., 2019</xref>; <xref ref-type="bibr" rid="B33">Lv et al., 2020</xref>), is one of the earliest signs. Such endothelial dysfunction might be affected by serum 8-iso-prostaglandin F2&#x3b1; (FIP), a specific sensitive indicator of OS that is involved in the pathophysiological changes of atherosclerosis (<xref ref-type="bibr" rid="B37">Mueller et al., 2004</xref>; <xref ref-type="bibr" rid="B32">Lepara et al., 2020</xref>). FMD of the brachial artery is a widely used parameter in evaluating the vascular endothelial function (<xref ref-type="bibr" rid="B54">Thijssen et al., 2011</xref>) and independently predicting the risk of cardiovascular diseases (<xref ref-type="bibr" rid="B10">Donato et al., 2018</xref>). Notably, although pro- and antioxidant factors are associated with endothelial dysfunction risk, the relationship between the holistic effect of these factors (evaluated by the OBS) and vascular endothelial function has not been reported. Additionally, associations between the OBS subgroups (such as the lifestyle- and diet-related OBS) and vascular endothelial functions are also informative in understanding how our living habits are associated with vascular endothelial conditions from the OS aspect.</p>
<p>Therefore, the present study calculated the OBS based on lifestyle- and diet-related pro- and antioxidant factors to investigate the OBS association with vascular endothelial function. Moreover, associations between the OBS components and endothelial function were analyzed to identify potential factors for vascular endothelial dysfunction prevention.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>2 Materials and methods</title>
<sec id="s2-1">
<title>2.1 Study population</title>
<p>A total of 382 residents from the Beijing Shunyi District volunteered to participate in this study. Of which, 42 people were excluded from the final analysis, in them 19 did not provide a blood sample, 16 did not complete the FMD measurement, and 7 did not complete the questionnaire. Finally, 339 Chinese Han ethnicity participants who could complete all the tests and questionnaires were included in this study, of whom 142 were male and 197 were female. Participants were recruited from a community in Beijing on a voluntary basis. The inclusion criteria were 1) aged 20&#x2013;75&#xa0;years, 2) long-term residents of the area, and 3) could complete all the test procedures and questionnaires as required. There were no special requirements for the health or disease status of the participants. The study protocol was approved by the Ethics Committee of Beijing Sport University (2017001H), and the study procedures were carried out in accordance with the Declaration of Helsinki. All participants were fully informed about the study and written consent forms were obtained from them.</p>
</sec>
<sec id="s2-2">
<title>2.2 Questionnaires</title>
<p>Some of the OS factors were collected by questionnaires. The questionnaires consisted of the long-form International Physical Activity Questionnaire (IPAQ) (Chinese version), which has been proven to have good validity and reliability in the Chinese population (<xref ref-type="bibr" rid="B43">Qu and Ji, 2004</xref>), and other questionnaires regarding the demographic characteristics (age, sex, and education), medical history (normal chronic diseases and use of medications, especially cardiovascular and cerebrovascular diseases), medication history (aspirin and NSAIDs used), smoking and alcohol consumption, family medical history, physical activity level, diet, and social habits. The questionnaires were completed by in-person interviews.</p>
</sec>
<sec id="s2-3">
<title>2.3 Basic medical checkup</title>
<p>Basic medical checkup included tests for height, weight, resting heart rate, and systolic (SBP) and diastolic (DBP) blood pressures. All instruments were calibrated before testing.</p>
</sec>
<sec id="s2-4">
<title>2.4 Blood tests and laboratory analyses</title>
<p>All subjects were required to fast at least 12&#xa0;h beforehand. Three milliliters of venous blood was drawn into a red-top tube. The blood sample was rested at room temperature for 10&#xa0;min and then centrifuged for 10&#xa0;min at 3000&#xa0;r/min speed. The serum was collected, aliquoted, and stored at &#x2212;80&#xb0;C for later analysis.</p>
<p>Triglyceride (TG), total cholesterol (TC), low-density lipoprotein (LDL), high-density lipoprotein (HDL), and blood glucose (BG) were measured by routine blood test. FIP, ferritin (FER), Vit C, unsaturated fatty acid-3 (&#x3c9;-3), and unsaturated fatty acid-6 (&#x3c9;-6) were measured with the double-antibody one-step sandwich method enzyme-linked immunosorbent assay (ELISA) using Beckman AU5800 (Beckman Coulter, California, America). Serum &#x3b1;-carotene, &#x3b2;-carotene, &#x3b2;-cryptoxanthin, zeaxanthin, &#x3b1;-tocopherol, and &#x3b3;-Toc were measured by high-performance liquid chromatography tandem mass spectrum using Shimadzu LC-20AD (Shimadzu, Kyoto, Japan) and AB Sciex API 3200MD Trap (Sciex, Boston, America).</p>
</sec>
<sec id="s2-5">
<title>2.5 Oxidative balance score</title>
<p>The overall OBS of this study was calculated by 16 pro- and antioxidant factors. In particular, there are two dietary prooxidants: &#x3c9;-6 and FER(<xref ref-type="bibr" rid="B56">Toborek et al., 1996</xref>; <xref ref-type="bibr" rid="B12">Ehara et al., 2001</xref>; <xref ref-type="bibr" rid="B19">Ghosh et al., 2006</xref>; <xref ref-type="bibr" rid="B60">Van Beelen et al., 2006</xref>; <xref ref-type="bibr" rid="B52">Syrovatka et al., 2011</xref>); eight dietary antioxidants: &#x3b1;-carotene, &#x3b2;-carotene, &#x3b2;-cryptoxanthin, zeaxanthin, &#x3b1;-tocopherol, &#x3b3;-tocopherol, Vit C, and &#x3c9;-3 (<xref ref-type="bibr" rid="B45">Rimm et al., 1993</xref>; <xref ref-type="bibr" rid="B15">Frei, 1994</xref>; <xref ref-type="bibr" rid="B57">Upritchard et al., 2003</xref>; <xref ref-type="bibr" rid="B28">Kinlay et al., 2004</xref>; <xref ref-type="bibr" rid="B53">Tamimi et al., 2005</xref>; <xref ref-type="bibr" rid="B3">Cai et al., 2010</xref>; <xref ref-type="bibr" rid="B34">Milani et al., 2017</xref>; <xref ref-type="bibr" rid="B14">Elvira-Torales et al., 2019</xref>; <xref ref-type="bibr" rid="B48">Snezhkina et al., 2019</xref>; <xref ref-type="bibr" rid="B51">Stupin et al., 2019</xref>; <xref ref-type="bibr" rid="B63">Yimcharoen et al., 2019</xref>; <xref ref-type="bibr" rid="B11">Drenjan&#x10d;evi&#x107; and Pitha, 2022</xref>; <xref ref-type="bibr" rid="B27">Khutami et al., 2022</xref>); three lifestyle prooxidants: BMI, smoking history, and alcohol consumption (<xref ref-type="bibr" rid="B26">Keaney et al., 2003</xref>; <xref ref-type="bibr" rid="B17">Furukawa et al., 2004</xref>; <xref ref-type="bibr" rid="B61">van der Vaart et al., 2004</xref>; <xref ref-type="bibr" rid="B16">Frohnert et al., 2011</xref>; <xref ref-type="bibr" rid="B4">Caliri et al., 2021</xref>); and three lifestyle antioxidants: physical activity level, aspirin, and NSAID use frequency (<xref ref-type="bibr" rid="B25">Kaur and Geetha, 2006</xref>; <xref ref-type="bibr" rid="B44">Radak et al., 2008</xref>). Factors with continuous variables were divided into categories based on the tertile values. Antioxidant factors in the lower, middle, and upper tertile groups were assigned zero, one, and two points, respectively. Reversely, prooxidant factors in the lower, middle, and upper tertile groups were assigned two, one, and zero points, respectively. The scores of the factors with categorical variables were assigned 0 to &#x2212;2 according to specific conditions. The detailed scoring criteria are shown in <xref ref-type="sec" rid="s11">Supplementary Table S1</xref>. The dietary OBS (ranging from 0 to 10) was calculated by summing the scores of the dietary pro- and antioxidant factors, and the lifestyle OBS (ranging from 0 to 6) was calculated by summing the scores of the lifestyle pro- and antioxidant factors.</p>
</sec>
<sec id="s2-6">
<title>2.6 Tests of vascular endothelial function</title>
<p>Brachial artery blood FMD was measured to estimate the vascular endothelia function. In particular, pressure was applied to the forearm to increase blood flow shear stress, resulting in increased synthesis and release of NO that causes vasodilation. Ultrasound (UNEX EF, Nagoya, Japan) was used to record the inner diameter changes of the blood vessels during the process, and the percentage change of the inner diameter was calculated as FMD. FMD lower than the threshold value (i.e., 5%) of the ultrasound machine indicated hypofunction of endothelium cells. The measurement was performed by a specialized technician.</p>
</sec>
<sec id="s2-7">
<title>2.7 Covariates</title>
<p>Age, sex, education level, TG, TC, LDL, HDL, SBP, DBP, cardiovascular diseases (yes/no), and diabetes (yes/no) were controlled in the analysis.</p>
</sec>
<sec id="s2-8">
<title>2.8 Statistical analysis</title>
<p>Data are presented as mean &#xb1; standard deviation. Group comparisons were performed using the <italic>t</italic>-test, chi-square test, or one-way analysis of variance (ANOVA) as appropriate. FIP and FMD were dichotomized into the &#x201c;low&#x201d; and &#x201c;high&#x201d; groups using their respective median values as the cutoff. The OBS was analyzed as overall OBS, dietary OBS, and lifestyle OBS tertiles. Logistic regression was used to analyze the OBS associations with FIP and FMD with adjustments made for covariates. Sensitivity analysis was further performed to complete each OBS component level between the low and high FIP and FMD groups (dichotomized by the corresponding median values) by independent samples <italic>t</italic>-test. Statistical significance was determined at a two-sided <italic>p</italic>-value of 0.05. Statistical analysis was performed using the SPSS statistical software version 23.0.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>3 Results</title>
<sec id="s3-1">
<title>3.1 Characteristics of participants</title>
<p>The demographic, dietary, and lifestyle characteristics of the participants are shown in <xref ref-type="table" rid="T1">Table 1</xref>. There are more female participants (58.11%), and their heights and weights were significantly lower than those of the male participants. There were no significant differences in BMI, Vit C, &#x3c9;-3, &#x3c9;-6, &#x3b2;-cryptoxanthin, zeaxanthin, &#x3b1;-tocopherol, &#x3b3;-Toc, and FIP between males and females. Higher &#x3b2;-carotene and lower &#x3b1;-carotene and FER were found in males than in females. Higher proportions of smoking and alcohol overconsumption were found in males than in females. The overall physical activity in male participants was lower than that in female participants. The proportion of females engaged in high physical activity was higher than that of males. There were no significant differences in the use of aspirin and NSAID between males and females.</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Descriptive characteristics of participants.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left"/>
<th align="center">All adults (<italic>n</italic> &#x3d; 339)</th>
<th align="center">Male (<italic>n</italic> &#x3d; 142)</th>
<th align="center">Female (<italic>n</italic> &#x3d; 197)</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">Age (years)</td>
<td align="center">53.0 &#xb1; 13.1</td>
<td align="center">51.8 &#xb1; 14.6</td>
<td align="center">53.9 &#xb1; 12.3</td>
</tr>
<tr>
<td align="left">Height (cm)</td>
<td align="center">160.05 &#xb1; 8.37</td>
<td align="center">166.90 &#xb1; 7.52</td>
<td align="center">155.12 &#xb1; 5.45&#x2a;&#x2a;</td>
</tr>
<tr>
<td align="left">Weight (kg)</td>
<td align="center">67.91 &#xb1; 11.02</td>
<td align="center">72.48 &#xb1; 10.71</td>
<td align="center">64.61 &#xb1; 10.22&#x2a;&#x2a;</td>
</tr>
<tr>
<td align="left">Body mass index (kg/m<sup>2</sup>)</td>
<td align="center">26.55 &#xb1; 3.79</td>
<td align="center">26.12 &#xb1; 3.52</td>
<td align="center">26.85 &#xb1; 3.92</td>
</tr>
<tr>
<td align="left">Vitamin C (umol/L)</td>
<td align="center">31.71 &#xb1; 9.26</td>
<td align="center">31.63 &#xb1; 9.77</td>
<td align="center">31.75 &#xb1; 9.02</td>
</tr>
<tr>
<td align="left">&#x3c9;-3 Fatty acid (umol/L)</td>
<td align="center">80.03 &#xb1; 21.37</td>
<td align="center">81.19 &#xb1; 25.29</td>
<td align="center">79.44 &#xb1; 19.12</td>
</tr>
<tr>
<td align="left">&#x3c9;-6 Fatty acid (umol/L)</td>
<td align="center">12.84 &#xb1; 3.42</td>
<td align="center">12.52 &#xb1; 3.58</td>
<td align="center">13.01 &#xb1; 3.34</td>
</tr>
<tr>
<td align="left">&#x3b1;-Carotene (ng/mL)</td>
<td align="center">19.71 &#xb1; 4.77</td>
<td align="center">18.68 &#xb1; 5.52</td>
<td align="center">20.23 &#xb1; 4.26&#x2a;</td>
</tr>
<tr>
<td align="left">&#x3b2;-Carotene (ng/mL)</td>
<td align="center">41.35 &#xb1; 10.89</td>
<td align="center">44.47 &#xb1; 12.23</td>
<td align="center">39.75 &#xb1; 9.81&#x2a;&#x2a;</td>
</tr>
<tr>
<td align="left">&#x3b2;-Cryptoxanthin (ng/mL)</td>
<td align="center">24.68 &#xb1; 7.93</td>
<td align="center">24.63 &#xb1; 8.55</td>
<td align="center">24.70 &#xb1; 7.62</td>
</tr>
<tr>
<td align="left">Zeaxanthin (ng/mL)</td>
<td align="center">29.53 &#xb1; 8.39</td>
<td align="center">28.35 &#xb1; 8.43</td>
<td align="center">30.14 &#xb1; 8.33</td>
</tr>
<tr>
<td align="left">&#x3b1;-Tocopherol (ng/mL)</td>
<td align="center">1795.85 &#xb1; 334.89</td>
<td align="center">1767.52 &#xb1; 415.97</td>
<td align="center">1810.37 &#xb1; 284.98</td>
</tr>
<tr>
<td align="left">&#x3b3;-Tocopherol (ng/mL)</td>
<td align="center">1068.37 &#xb1; 257.13</td>
<td align="center">1082.92 &#xb1; 285.36</td>
<td align="center">1060.91 &#xb1; 241.99</td>
</tr>
<tr>
<td align="left">Ferritin (ng/mL)</td>
<td align="center">57.38 &#xb1; 8.56</td>
<td align="center">55.39 &#xb1; 8.84</td>
<td align="center">58.39 &#xb1; 8.26&#x2a;&#x2a;</td>
</tr>
<tr>
<td align="left">8-Iso-PGF<sub>2&#x3b1;</sub> (pg/mL)</td>
<td align="center">517.97 &#xb1; 78.41</td>
<td align="center">523.27 &#xb1; 83.12</td>
<td align="center">515.26 &#xb1; 76.01</td>
</tr>
<tr>
<td align="left">Current smoking (%)</td>
<td align="center">88 (25.96)</td>
<td align="center">83 (58.45)</td>
<td align="center">5 (2.54)&#x2a;&#x2a;</td>
</tr>
<tr>
<td align="left">Current alcohol user (%)</td>
<td align="center">52 (15.34)</td>
<td align="center">48 (33.80)</td>
<td align="center">4 (2.03)&#x2a;&#x2a;</td>
</tr>
<tr>
<td align="left">Low physical activity (%)</td>
<td align="center">24 (7.08)</td>
<td align="center">17 (11.97)</td>
<td align="center">7 (3.55)&#x2a;&#x2a;</td>
</tr>
<tr>
<td align="left">Medium physical activity (%)</td>
<td align="center">101 (29.79)</td>
<td align="center">47 (33.10)</td>
<td align="center">54 (27.41)</td>
</tr>
<tr>
<td align="left">High physical activity (%)</td>
<td align="center">214 (63.13)</td>
<td align="center">78 (54.93)</td>
<td align="center">136 (69.04)&#x2a;&#x2a;</td>
</tr>
<tr>
<td align="left">NSAID user (%)</td>
<td align="center">117 (34.51)</td>
<td align="center">47 (33.10)</td>
<td align="center">70 (35.53)</td>
</tr>
<tr>
<td align="left">Aspirin user (%)</td>
<td align="center">85 (25.07)</td>
<td align="center">40 (28.17)</td>
<td align="center">45 (22.84)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>&#x2a;<italic>p</italic> &#x3c; 0.05, &#x2a;&#x2a;<italic>p</italic> &#x3c; 0.01, when compared with males based on the <italic>t</italic>-test for continuous variables and chi-square test for categorical variables.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3-2">
<title>3.2 Comparisons of OBS components in stratified FIP and FMD groups</title>
<p>Comparisons of all OBS components between the stratified FIP groups are shown in <xref ref-type="table" rid="T2">Table 2</xref>. All the eight dietary antioxidants were higher in the low FIP group than high FIP group. Both dietary prooxidants (i.e., &#x3c9;-6 and FER) were lower in the low FIP group. The proportion of participants with lifestyle antioxidants (aspirin use frequency) and prooxidants (i.e., smoking and alcohol consumption) were lower in the low FIP group than in the high FIP group.</p>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>Comparisons of OBS components between high and low FIP levels.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th colspan="2" align="center">OBS components</th>
<th align="center">Low FIP (<italic>n</italic> &#x3d; 159)</th>
<th align="center">High FIP (<italic>n</italic> &#x3d; 180)</th>
<th align="center">
<italic>p</italic>-value</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td rowspan="6" align="center">Prooxidant factors</td>
<td align="left">BMI (kg/m<sup>2</sup>)</td>
<td align="center">26.08 &#xb1; 4.29</td>
<td align="center">26.98 &#xb1; 3.21</td>
<td align="center">0.062</td>
</tr>
<tr>
<td align="left">Low physical activity (%)</td>
<td align="center">13 (8.18)</td>
<td align="center">11 (6.11)</td>
<td align="center">0.459</td>
</tr>
<tr>
<td align="left">Smoking (%)</td>
<td align="center">32 (20.12)</td>
<td align="center">56 (31.11)</td>
<td align="center">0.021</td>
</tr>
<tr>
<td align="left">Above-median alcohol user (%)</td>
<td align="center">14 (8.81)</td>
<td align="center">38 (21.11)</td>
<td align="center">0.002</td>
</tr>
<tr>
<td align="left">Serum ferritin (ng/mL)</td>
<td align="center">52.82 &#xb1; 8.80</td>
<td align="center">61.01 &#xb1; 6.01</td>
<td align="center">0.001</td>
</tr>
<tr>
<td align="left">&#x3c9;-6 Fatty acid (umol/L)</td>
<td align="center">11.79 &#xb1; 3.39</td>
<td align="center">13.63 &#xb1; 3.16</td>
<td align="center">0.001</td>
</tr>
<tr>
<td rowspan="10" align="center">Antioxidant factors</td>
<td align="left">Vitamin C (umol/L)</td>
<td align="center">35.13 &#xb1; 9.17</td>
<td align="center">28.91 &#xb1; 8.39</td>
<td align="center">0.001</td>
</tr>
<tr>
<td align="left">&#x3c9;-3 Fatty acid (umol/L)</td>
<td align="center">87.98 &#xb1; 22.49</td>
<td align="center">73.60 &#xb1; 17.87</td>
<td align="center">0.001</td>
</tr>
<tr>
<td align="left">&#x3b1;-Carotene (ng/mL)</td>
<td align="center">21.14 &#xb1; 4.99</td>
<td align="center">18.55 &#xb1; 4.26</td>
<td align="center">0.001</td>
</tr>
<tr>
<td align="left">&#x3b2;-Carotene (ng/mL)</td>
<td align="center">45.32 &#xb1; 10.50</td>
<td align="center">38.29 &#xb1; 9.97</td>
<td align="center">0.001</td>
</tr>
<tr>
<td align="left">&#x3b2;-cryptoxanthin (ng/mL)</td>
<td align="center">26.69 &#xb1; 8.00</td>
<td align="center">23.19 &#xb1; 7.48</td>
<td align="center">0.001</td>
</tr>
<tr>
<td align="left">Zeaxanthin (ng/mL)</td>
<td align="center">32.32 &#xb1; 8.47</td>
<td align="center">27.30 &#xb1; 7.62</td>
<td align="center">0.001</td>
</tr>
<tr>
<td align="left">&#x3b1;-Tocopherol (ng/mL)</td>
<td align="center">1947.94 &#xb1; 353.58</td>
<td align="center">1669.05 &#xb1; 257.58</td>
<td align="center">0.001</td>
</tr>
<tr>
<td align="left">&#x3b3;-Tocopherol (ng/mL)</td>
<td align="center">1205.31 &#xb1; 257.67</td>
<td align="center">958.08 &#xb1; 190.55</td>
<td align="center">0.001</td>
</tr>
<tr>
<td align="left">Aspirin user (%)</td>
<td align="center">21 (13.21)</td>
<td align="center">64 (35.56)</td>
<td align="center">0.001</td>
</tr>
<tr>
<td align="left">NSAID user (%)</td>
<td align="center">51 (32.07)</td>
<td align="center">66 (36.67)</td>
<td align="center">0.375</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Comparisons of all OBS components between the stratified FMD groups are shown in <xref ref-type="table" rid="T3">Table 3</xref>. Four dietary antioxidants (&#x3b1;-carotene, zeaxanthin, &#x3b1;-tocopherol, and &#x3b3;-Toc) were higher in the high FMD group than the low FMD group, while other pro- and antioxidants failed to show differences between the FMD groups.</p>
<table-wrap id="T3" position="float">
<label>TABLE 3</label>
<caption>
<p>Comparisons of OBS components between high and low FMD levels.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th colspan="2" align="center">OBS components</th>
<th align="center">Low FMD (<italic>n</italic> &#x3d; 192)</th>
<th align="center">High FMD (<italic>n</italic> &#x3d; 147)</th>
<th align="center">
<italic>p</italic>-value</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td rowspan="6" align="left">Prooxidant factors</td>
<td align="left">BMI (kg/m<sup>2</sup>)</td>
<td align="center">26.43 &#xb1; 3.70</td>
<td align="center">26.83 &#xb1; 3.99</td>
<td align="center">0.420</td>
</tr>
<tr>
<td align="left">Low physical activity (%)</td>
<td align="center">15 (7.90)</td>
<td align="center">9 (6.90)</td>
<td align="center">0.490</td>
</tr>
<tr>
<td align="left">Smoking (%)</td>
<td align="center">56 (29.60)</td>
<td align="center">32 (21.30)</td>
<td align="center">0.084</td>
</tr>
<tr>
<td align="left">Above-median alcohol user (%)</td>
<td align="center">33 (17.50)</td>
<td align="center">19 (12.70)</td>
<td align="center">0.224</td>
</tr>
<tr>
<td align="left">Serum ferritin (ng/mL)</td>
<td align="center">58.06 &#xb1; 7.86</td>
<td align="center">56.09 &#xb1; 9.13</td>
<td align="center">0.072</td>
</tr>
<tr>
<td align="left">&#x3c9;-6 Fatty acid (umol/L)</td>
<td align="center">12.60 &#xb1; 3.39</td>
<td align="center">12.98 &#xb1; 3.39</td>
<td align="center">0.389</td>
</tr>
<tr>
<td rowspan="10" align="left">Antioxidant factors</td>
<td align="left">Vitamin C (umol/L)</td>
<td align="center">30.83 &#xb1; 9.49</td>
<td align="center">33.05 &#xb1; 8.90</td>
<td align="center">0.064</td>
</tr>
<tr>
<td align="left">&#x3c9;-3 Fatty acid (umol/L)</td>
<td align="center">78.90 &#xb1; 21.96</td>
<td align="center">82.10 &#xb1; 20.55</td>
<td align="center">0.246</td>
</tr>
<tr>
<td align="left">&#x3b1;-Carotene (ng/mL)</td>
<td align="center">19.12 &#xb1; 4.74</td>
<td align="center">20.58 &#xb1; 4.74</td>
<td align="center">0.018</td>
</tr>
<tr>
<td align="left">&#x3b2;-Carotene (ng/mL)</td>
<td align="center">40.93 &#xb1; 10.57</td>
<td align="center">42.40 &#xb1; 11.04</td>
<td align="center">0.289</td>
</tr>
<tr>
<td align="left">&#x3b2;-Cryptoxanthin (ng/mL)</td>
<td align="center">24.79 &#xb1; 8.30</td>
<td align="center">24.86 &#xb1; 7.40</td>
<td align="center">0.946</td>
</tr>
<tr>
<td align="left">Zeaxanthin (ng/mL)</td>
<td align="center">27.97 &#xb1; 8.01</td>
<td align="center">31.75 &#xb1; 8.43</td>
<td align="center">0.001</td>
</tr>
<tr>
<td align="left">&#x3b1;-Tocopherol (ng/mL)</td>
<td align="center">1754.24 &#xb1; 366.24</td>
<td align="center">1856.16 &#xb1; 284.77</td>
<td align="center">0.018</td>
</tr>
<tr>
<td align="left">&#x3b3;-Tocopherol (ng/mL)</td>
<td align="center">1043.20 &#xb1; 237.40</td>
<td align="center">1111.85 &#xb1; 273.55</td>
<td align="center">0.037</td>
</tr>
<tr>
<td align="left">Aspirin user (%)</td>
<td align="center">55 (28.65)</td>
<td align="center">30 (20.41)</td>
<td align="center">0.083</td>
</tr>
<tr>
<td align="left">NSAID user (%)</td>
<td align="center">69 (35.94)</td>
<td align="center">48 (32.65)</td>
<td align="center">0.528</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s3-3">
<title>3.3 Associations between different types of OBS, FIP, and FMD</title>
<p>The overall OBS was stratified by the upper tertile cutoff value of 19 and lower tertile cutoff value of 15 (<xref ref-type="bibr" rid="B39">Noruzi et al., 2021</xref>). The dietary OBS was stratified by the upper and lower tertile cutoff values of 13 and 8, respectively. The lifestyle OBS was stratified by the upper and lower tertile cutoff values of 8 and 6, respectively. Logistic regression on the stratified FIP groups (stratified by the median value of 516.73&#xa0;pg/mL) showed that higher overall and dietary OBSs were associated with a lower chance of developing high FIP (<xref ref-type="table" rid="T4">Table 4</xref>). Particularly, the odds ratio of becoming the high FIP group was 0.17 (95% CI: 0.086&#x2013;0.355) between the middle and lower overall OBS groups, and 0.054 (95% CI: 0.025&#x2013;0.115) between the higher and lower overall OBS groups. The odds ratio of becoming the FIP group was 0.24 (95% CI: 0.123&#x2013;0.467) between the middle and lower dietary OBS groups, and 0.041 (95% CI: 0.017&#x2013;0.099) between the higher and lower dietary OBS groups. Similarly, logistic regression on the stratified FMD groups (stratified by the median value of 10.70%) showed that higher overall and dietary OBSs were associated with a lower chance of developing low FMD (<xref ref-type="table" rid="T5">Table 5</xref>). The odds ratio of becoming the low FMD group was 0.535 (95% CI: 0.289&#x2013;0.992) between the middle and lower Overall OBS groups, and 0.397 (95% CI: 0.206&#x2013;0.766) between the higher and lower overall BOS groups. The odds ratio of becoming the low FMD group was 0.455 (95% CI: 0.248&#x2013;0.836) between the higher and lower dietary OBS groups.</p>
<table-wrap id="T4" position="float">
<label>TABLE 4</label>
<caption>
<p>Results of logistic regression between OBS and FIP.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left"/>
<th align="left"/>
<th align="center">AOR</th>
<th align="center">95% CI</th>
<th align="center">
<italic>p</italic>-value</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td rowspan="3" align="left">Overall OBS</td>
<td align="center">Tertile 1</td>
<td align="center">Ref</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
</tr>
<tr>
<td align="center">Tertile 2</td>
<td align="center">0.170</td>
<td align="center">0.086&#x2013;0.335</td>
<td align="center">0.001</td>
</tr>
<tr>
<td align="center">Tertile 3</td>
<td align="center">0.054</td>
<td align="center">0.025&#x2013;0.115</td>
<td align="center">0.001</td>
</tr>
<tr>
<td rowspan="3" align="left">Dietary OBS</td>
<td align="center">Tertile 1</td>
<td align="center">Ref</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
</tr>
<tr>
<td align="center">Tertile 2</td>
<td align="center">0.240</td>
<td align="center">0.123&#x2013;0.467</td>
<td align="center">0.001</td>
</tr>
<tr>
<td align="center">Tertile 3</td>
<td align="center">0.041</td>
<td align="center">0.017&#x2013;0.099</td>
<td align="center">0.001</td>
</tr>
<tr>
<td rowspan="3" align="left">Lifestyle OBS</td>
<td align="center">Tertile 1</td>
<td align="center">Ref</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
</tr>
<tr>
<td align="center">Tertile 2</td>
<td align="center">0.984</td>
<td align="center">0.522&#x2013;1.853</td>
<td align="center">0.959</td>
</tr>
<tr>
<td align="center">Tertile 3</td>
<td align="center">0.634</td>
<td align="center">0.309&#x2013;1.300</td>
<td align="center">0.214</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>CI, confidence interval; AOR, adjusted odds ratio controlling for age, sex, education, fitness, tri-glycerides, total cholesterol, LDL-cholesterol, HDL-cholesterol, systolic pressure, diastolic pressure, cardiovascular disease, and diabetes. In addition, the dietary OBS was adjusted for lifestyle OBS components, and the lifestyle OBS was adjusted for dietary OBS components.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="T5" position="float">
<label>TABLE 5</label>
<caption>
<p>Results of logistic regression between OBS and FMD.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left"/>
<th align="left"/>
<th align="center">AOR</th>
<th align="center">95% CI</th>
<th align="center">
<italic>p</italic>-value</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td rowspan="3" align="left">Overall OBS</td>
<td align="center">Tertile 1</td>
<td align="center">Ref</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
</tr>
<tr>
<td align="center">Tertile 2</td>
<td align="center">0.535</td>
<td align="center">0.289&#x2013;0.992</td>
<td align="center">0.047</td>
</tr>
<tr>
<td align="center">Tertile 3</td>
<td align="center">0.397</td>
<td align="center">0.206&#x2013;0.766</td>
<td align="center">0.006</td>
</tr>
<tr>
<td rowspan="3" align="left">Dietary OBS</td>
<td align="center">Tertile 1</td>
<td align="center">Ref</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
</tr>
<tr>
<td align="center">Tertile 2</td>
<td align="center">0.621</td>
<td align="center">0.332&#x2013;1.160</td>
<td align="center">0.135</td>
</tr>
<tr>
<td align="center">Tertile 3</td>
<td align="center">0.455</td>
<td align="center">0.248&#x2013;0.836</td>
<td align="center">0.011</td>
</tr>
<tr>
<td rowspan="3" align="left">Lifestyle OBS</td>
<td align="center">Tertile 1</td>
<td align="center">Ref</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
</tr>
<tr>
<td align="center">Tertile 2</td>
<td align="center">0.571</td>
<td align="center">0.312&#x2013;1.044</td>
<td align="center">0.069</td>
</tr>
<tr>
<td align="center">Tertile 3</td>
<td align="center">1.061</td>
<td align="center">0.513&#x2013;2.196</td>
<td align="center">0.873</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>CI, confidence interval; AOR, adjusted odds ratio, controlling for age, sex, education, fitness, tri-glycerides, total cholesterol, LDL-cholesterol, HDL-cholesterol, systolic pressure, diastolic pressure, cardiovascular disease, and diabetes. In addition, the dietary OBS was adjusted for lifestyle OBS components, and the lifestyle OBS was adjusted for dietary OBS components.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>4 Discussion</title>
<p>The current study calculated the OBS based on 16 pro- and antioxidant factors to evaluate the influence of the ROS on the oxidative status in Chinese community dwellers. FIP was measured to estimate the OS level, and FMD was measured to evaluate the endothelial function. Our analyses showed that lower overall OBS and dietary OBS were associated with higher OS levels (i.e., a higher FIP value) and worse endothelial functions (i.e., a lower FMD value). Analyses on the OBS components showed that dietary and lifestyle pro- and antioxidant factors were associated with OS. Meanwhile, four dietary antioxidants (&#x3b1;-carotene, zeaxanthin, &#x3b1;-tocopherol, and &#x3b3;-Toc) were associated with the endothelial function.</p>
<p>Recent studies have indicated that endothelial dysfunction may predict long-term atherosclerotic disease progression and cardiovascular event occurrence (<xref ref-type="bibr" rid="B13">El Assar et al., 2013</xref>). Although the mechanisms underlying endothelial dysfunction are multifactorial, cumulative evidence suggest that OS can directly affect the vascular function and tone by oxidative modification of proteins or nucleic acids. A major mechanism for the impact of OS on vascular tone is the decrease of NO bioavailability and/or signaling, leading to endothelial dysfunction. Additionally, excessive ROS may also promote vascular cell proliferation and migration, inflammation, and apoptosis, as well as extracellular matrix alterations (<xref ref-type="bibr" rid="B47">Schulz et al., 2011</xref>). Therefore, OS is a major cause of endothelial dysfunction (<xref ref-type="bibr" rid="B23">Incalza et al., 2018</xref>). The OBS has become a popular tool in evaluating the global OS status with diseases. Lower OBSs are associated with higher OS status and increased risk of hypertension (<xref ref-type="bibr" rid="B1">Annor et al., 2015</xref>), prostate cancer, and colon cancer (<xref ref-type="bibr" rid="B29">Kong et al., 2014</xref>). The current study extended the association between the OBS and OS by showing that the OBS was reversely associated with the OS status (reflected by serum FIP) in Chinese community dwellers. FIP is commonly used to evaluate lipid oxidative damage (<xref ref-type="bibr" rid="B18">G&#xe0;o et al., 2018</xref>). FIP is a member of the F2-isoprostane family, which includes prostaglandin-like compounds produced by non-enzymatic peroxidation of arachidonic acid (<xref ref-type="bibr" rid="B40">Nourooz-Zadeh, 2008</xref>). Multiple studies have shown that FIP is a reliable marker of oxidative stress <italic>in vivo</italic> (<xref ref-type="bibr" rid="B36">Morrow, 2005</xref>; <xref ref-type="bibr" rid="B35">Milne et al., 2007</xref>). Considering the convenience of collecting data for the OBS, this parameter might be a potential surrogate of FIP for evaluating the OS status.</p>
<p>The OBS components are mainly derived from diet and lifestyle, where the former are nutrients while the latter are lifestyle-related factors, such as smoking, alcohol consumption, physical activity, and the use of medicine. To explore the impact of diet and lifestyle on endothelial function, the corresponding OBS was analyzed separately. The results have shown that the dietary OBS, rather than the lifestyle OBS, is significantly associated with endothelial function, indicating that nutrients might play a more important role than lifestyle in regulating endothelial function. Notably, four dietary antioxidants (&#x3b1;-carotene, zeaxanthin, &#x3b1;-tocopherol, and &#x3b3;-Toc) have shown significant differences between high and low endothelial function groups. Such results are consistent with previous research on the supplementation of antioxidants and diseases (<xref ref-type="bibr" rid="B12">Ehara et al., 2001</xref>; <xref ref-type="bibr" rid="B60">Van Beelen et al., 2006</xref>) in which some pro- or antioxidants alone have no direct relationship with the occurrence and development of diseases. Meanwhile, a previous study found that the lifestyle OBS was more significantly associated with adenoma incidence than the dietary OBS, and the physical activity level in lifestyle was more important for colorectal adenoma than components in dietary (<xref ref-type="bibr" rid="B29">Kong et al., 2014</xref>). Such inconsistent findings of the dietary OBS and lifestyle OBS in previous disease studies have indicated that the importance of diet- and lifestyle-related OS might vary with diseases.</p>
<p>In this cross-sectional study, we examined the associations between FIP and the different types of OBSs and found that the dietary OBS had a strong, statistically significant inverse association with FIP, but the lifestyle OBS had no such association with FIP. In the analysis of the associations between the FIP and OBS components, we observed that all components showed significant differences between low FIP and high FIP groups except BMI and low physical activity. Such results are within our expectation since antioxidants can lower the body&#x2019;s oxidative status and prooxidants exert the opposite effect. We also found a discrepant result that the proportions of aspirin use in the high FIP group were significantly higher than those in the low FIP group despite that the use of these medicines should have been in favor of lowering FIP. A possible explanation might be the bias of medicinal usage among participants. Specifically, people begin taking aspirin only after the onset of hypertension, hyperlipidemia, and other cardiovascular and cerebrovascular diseases that are closely related to the oxidative status. Consequently, people with comparatively high oxidative status tend to use aspirin, while others with a lower oxidative status do not take these medicines actively.</p>
<p>One of the strengths of this study is that the micronutrient levels were measured from samples instead of being estimated by food frequency questionnaire. Therefore, our OBS calculation on diet-related pro- and antioxidants is quite accurate. Separate analyses of the dietary OBS and lifestyle OBS is another novelty, which helped clarify the aspect of OBS that contributes more to endothelial function. Furthermore, the analyses of their associations with OS and vascular endothelial function helped explore the main factors influencing the vascular endothelial function to identify and propose preventive measures. The limitation of this study is that it is a cross-sectional and of limited sample size. Therefore, the current research conclusion should be treated with caution. In addition, the study population is limited to Chinese community dwellers, and some aspects of their lifestyle are less diverse, therefore it is unclear if these findings can be generalized to other populations. The OBS was limited to dietary/lifestyle exposures and failed to include endogenous enzymatic mechanisms (e.g., superoxide dismutase, glutathione peroxidase, and catalase), which might also affect the oxidative balance by clearing free radicals and reducing OS (<xref ref-type="bibr" rid="B59">Valko et al., 2016</xref>; <xref ref-type="bibr" rid="B24">Kattoor et al., 2017</xref>).</p>
<p>In conclusion, this study analyzed the association between the oxidative balance score and vascular endothelial function. The overall oxidative balance score reflects the body&#x2019;s oxidative stress status and was found negatively associated with endothelial function. The dietary-related oxidative balance score was more closely associated with vascular endothelial function when compared with the lifestyle-related one.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s5">
<title>Data availability statement</title>
<p>The raw data supporting the conclusion of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec id="s6">
<title>Ethics statement</title>
<p>The studies involving human participants were reviewed and approved by the Ethics Committee of Beijing Sport University. The patients/participants provided their written informed consent to participate in this study.</p>
</sec>
<sec id="s7">
<title>Author contributions</title>
<p>LZ designed the experiments; JL, YL, AW, and CW carried out the experiments. JL, AW, YL, KX, HH, and CW analyzed the results and performed statistical analysis in collaboration with LH; and JL wrote the manuscript with help from LH and LZ. LZ and LH share primary responsibility for the final content. All authors have read and approved the final manuscript.</p>
</sec>
<sec id="s8">
<title>Funding</title>
<p>This research is funded by the National Key R&#x26;D Program of China (2022YFC3600201); Chinese Universities Scientific Fund (2017SYS008, 2022YB012).</p>
</sec>
<ack>
<p>The authors would like to thank all investigators, the staff, and the participants of this project for their valuable contributions.</p>
</ack>
<sec sec-type="COI-statement" id="s9">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s10">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, editors, and reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s11">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fphys.2023.1076327/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fphys.2023.1076327/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="Table1.DOCX" id="SM1" mimetype="application/DOCX" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Annor</surname>
<given-names>F. B.</given-names>
</name>
<name>
<surname>Goodman</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Okosun</surname>
<given-names>I. S.</given-names>
</name>
<name>
<surname>Wilmot</surname>
<given-names>D. W.</given-names>
</name>
<name>
<surname>Il&#x27;yasova</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Ndirangu</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Oxidative stress, oxidative balance score, and hypertension among a racially diverse population</article-title>. <source>J. Am. Soc. Hypertens.</source> <volume>9</volume> (<issue>8</issue>), <fpage>592</fpage>&#x2013;<lpage>599</lpage>. <pub-id pub-id-type="doi">10.1016/j.jash.2015.05.014</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Antelava</surname>
<given-names>N. A.</given-names>
</name>
<name>
<surname>Pachkoriia</surname>
<given-names>K. Z.</given-names>
</name>
<name>
<surname>Kezeli</surname>
<given-names>T. D.</given-names>
</name>
<name>
<surname>Nikuradze</surname>
<given-names>N. S.</given-names>
</name>
<name>
<surname>Shamkulashvili</surname>
<given-names>G. G.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Major pathogenic links of atherosclerosis</article-title>. <source>Georgian Med. News</source> <volume>128</volume>, <fpage>72</fpage>&#x2013;<lpage>79</lpage>.</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cai</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Hui</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Gong</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Evaluation of external quenching singlet oxygen capacity of &#x3b2;-cryptoxanthin in calyx alkekengy</article-title>. <source>Food Sci.</source> <volume>31</volume> (<issue>17</issue>), <fpage>158</fpage>&#x2013;<lpage>161</lpage>.</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caliri</surname>
<given-names>A. W.</given-names>
</name>
<name>
<surname>Tommasi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Besaratinia</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Relationships among smoking, oxidative stress, inflammation, macromolecular damage, and cancer</article-title>. <source>Mutat. Res. Rev. Mutat. Res.</source> <volume>787</volume>, <fpage>108365</fpage>. <pub-id pub-id-type="doi">10.1016/j.mrrev.2021.108365</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cathcart</surname>
<given-names>M. K.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Regulation of superoxide anion production by NADPH oxidase in monocytes/macrophages: Contributions to atherosclerosis</article-title>. <source>Arterioscler. Thromb. Vasc. Biol.</source> <volume>24</volume> (<issue>1</issue>), <fpage>23</fpage>&#x2013;<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1161/01.Atv.0000097769.47306.12</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cersosimo</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>DeFronzo</surname>
<given-names>R. A.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Insulin resistance and endothelial dysfunction: The road map to cardiovascular diseases</article-title>. <source>Diabetes Metab. Res. Rev.</source> <volume>22</volume> (<issue>6</issue>), <fpage>423</fpage>&#x2013;<lpage>436</lpage>. <pub-id pub-id-type="doi">10.1002/dmrr.634</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cort&#xe9;s-Jofr&#xe9;</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rueda</surname>
<given-names>J. R.</given-names>
</name>
<name>
<surname>Asenjo-Lobos</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Madrid</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Bonfill Cosp</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Drugs for preventing lung cancer in healthy people</article-title>. <source>Cochrane Database Syst. Rev.</source> <volume>3</volume> (<issue>3</issue>), <fpage>Cd002141</fpage>. <pub-id pub-id-type="doi">10.1002/14651858.CD002141.pub3</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dash</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Goodman</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Flanders</surname>
<given-names>W. D.</given-names>
</name>
<name>
<surname>Mink</surname>
<given-names>P. J.</given-names>
</name>
<name>
<surname>McCullough</surname>
<given-names>M. L.</given-names>
</name>
<name>
<surname>Bostick</surname>
<given-names>R. M.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Using pathway-specific comprehensive exposure scores in epidemiology: Application to oxidative balance in a pooled case-control study of incident, sporadic colorectal adenomas</article-title>. <source>Am. J. Epidemiol.</source> <volume>178</volume> (<issue>4</issue>), <fpage>610</fpage>&#x2013;<lpage>624</lpage>. <pub-id pub-id-type="doi">10.1093/aje/kwt007</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dokken</surname>
<given-names>B. B.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>The pathophysiology of cardiovascular disease and diabetes: Beyond blood pressure and lipids</article-title>. <source>Diabetes Spectr.</source> <volume>21</volume> (<issue>3</issue>), <fpage>160</fpage>&#x2013;<lpage>165</lpage>. <pub-id pub-id-type="doi">10.2337/diaspect.21.3.160</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Donato</surname>
<given-names>A. J.</given-names>
</name>
<name>
<surname>Machin</surname>
<given-names>D. R.</given-names>
</name>
<name>
<surname>Lesniewski</surname>
<given-names>L. A.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Mechanisms of dysfunction in the aging vasculature and role in age-related disease</article-title>. <source>Circ. Res.</source> <volume>123</volume> (<issue>7</issue>), <fpage>825</fpage>&#x2013;<lpage>848</lpage>. <pub-id pub-id-type="doi">10.1161/circresaha.118.312563</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Drenjan&#x10d;evi&#x107;</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Pitha</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Omega-3 polyunsaturated fatty acids-vascular and cardiac effects on the cellular and molecular level (narrative review)</article-title>. <source>Int. J. Mol. Sci.</source> <volume>23</volume> (<issue>4</issue>), <fpage>2104</fpage>. <pub-id pub-id-type="doi">10.3390/ijms23042104</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ehara</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ueda</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Naruko</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Haze</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Itoh</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Otsuka</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2001</year>). <article-title>Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes</article-title>. <source>Circulation</source> <volume>103</volume> (<issue>15</issue>), <fpage>1955</fpage>&#x2013;<lpage>1960</lpage>. <pub-id pub-id-type="doi">10.1161/01.cir.103.15.1955</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>El Assar</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Angulo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Rodr&#xed;guez-Ma&#xf1;as</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Oxidative stress and vascular inflammation in aging</article-title>. <source>Free Radic. Biol. Med.</source> <volume>65</volume>, <fpage>380</fpage>&#x2013;<lpage>401</lpage>. <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2013.07.003</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elvira-Torales</surname>
<given-names>L. I.</given-names>
</name>
<name>
<surname>Garc&#xed;a-Alonso</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Periago-Cast&#xf3;n</surname>
<given-names>M. J.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Nutritional importance of carotenoids and their effect on liver health: A review</article-title>. <source>Antioxidants (Basel)</source> <volume>8</volume> (<issue>7</issue>), <fpage>229</fpage>. <pub-id pub-id-type="doi">10.3390/antiox8070229</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frei</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>1994</year>). <article-title>Reactive oxygen species and antioxidant vitamins: Mechanisms of action</article-title>. <source>Am. J. Med.</source> <volume>97</volume>, <fpage>5S</fpage>&#x2013;<lpage>13S; discussion 22S-28S</lpage>. <pub-id pub-id-type="doi">10.1016/0002-9343(94)90292-5</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frohnert</surname>
<given-names>B. I.</given-names>
</name>
<name>
<surname>Sinaiko</surname>
<given-names>A. R.</given-names>
</name>
<name>
<surname>Serrot</surname>
<given-names>F. J.</given-names>
</name>
<name>
<surname>Foncea</surname>
<given-names>R. E.</given-names>
</name>
<name>
<surname>Moran</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ikramuddin</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>Increased adipose protein carbonylation in human obesity</article-title>. <source>Obes. (Silver Spring)</source> <volume>19</volume> (<issue>9</issue>), <fpage>1735</fpage>&#x2013;<lpage>1741</lpage>. <pub-id pub-id-type="doi">10.1038/oby.2011.115</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Furukawa</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Fujita</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Shimabukuro</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Iwaki</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yamada</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Nakajima</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2004</year>). <article-title>Increased oxidative stress in obesity and its impact on metabolic syndrome</article-title>. <source>J. Clin. Invest.</source> <volume>114</volume> (<issue>12</issue>), <fpage>1752</fpage>&#x2013;<lpage>1761</lpage>. <pub-id pub-id-type="doi">10.1172/jci21625</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>G&#xe0;o</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Brenner</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Holleczek</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Cuk</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Anusruti</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Urinary 8-isoprostane levels and occurrence of lung, colorectal, prostate, breast and overall cancer: Results from a large, population-based cohort study with 14 years of follow-up</article-title>. <source>Free Radic. Biol. Med.</source> <volume>123</volume>, <fpage>20</fpage>&#x2013;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2018.05.065</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghosh</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kewalramani</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Yuen</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Pulinilkunnil</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>An</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Innis</surname>
<given-names>S. M.</given-names>
</name>
<etal/>
</person-group> (<year>2006</year>). <article-title>Induction of mitochondrial nitrative damage and cardiac dysfunction by chronic provision of dietary omega-6 polyunsaturated fatty acids</article-title>. <source>Free Radic. Biol. Med.</source> <volume>41</volume> (<issue>9</issue>), <fpage>1413</fpage>&#x2013;<lpage>1424</lpage>. <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2006.07.021</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Griendling</surname>
<given-names>K. K.</given-names>
</name>
<name>
<surname>Camargo</surname>
<given-names>L. L.</given-names>
</name>
<name>
<surname>Rios</surname>
<given-names>F. J.</given-names>
</name>
<name>
<surname>Alves-Lopes</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Montezano</surname>
<given-names>A. C.</given-names>
</name>
<name>
<surname>Touyz</surname>
<given-names>R. M.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Oxidative stress and hypertension</article-title>. <source>Circ. Res.</source> <volume>128</volume> (<issue>7</issue>), <fpage>993</fpage>&#x2013;<lpage>1020</lpage>. <pub-id pub-id-type="doi">10.1161/circresaha.121.318063</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<collab>Heart Protection Study Collaborative Group</collab> (<year>2002</year>). <article-title>MRC/BHF heart protection study of antioxidant vitamin supplementation in 20,536 high-risk individuals: A randomised placebo-controlled trial</article-title>. <source>Lancet</source> <volume>360</volume> (<issue>9326</issue>), <fpage>23</fpage>&#x2013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1016/s0140-6736(02)09328-5</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ilori</surname>
<given-names>T. O.</given-names>
</name>
<name>
<surname>Sun Ro</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>S. Y.</given-names>
</name>
<name>
<surname>Gutierrez</surname>
<given-names>O. M.</given-names>
</name>
<name>
<surname>Ojo</surname>
<given-names>A. O.</given-names>
</name>
<name>
<surname>Judd</surname>
<given-names>S. E.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Oxidative balance score and chronic kidney disease</article-title>. <source>Am. J. Nephrol.</source> <volume>42</volume> (<issue>4</issue>), <fpage>320</fpage>&#x2013;<lpage>327</lpage>. <pub-id pub-id-type="doi">10.1159/000441623</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Incalza</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>D&#x27;Oria</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Natalicchio</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Perrini</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Laviola</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Giorgino</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases</article-title>. <source>Vasc. Pharmacol.</source> <volume>100</volume>, <fpage>1</fpage>&#x2013;<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1016/j.vph.2017.05.005</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kattoor</surname>
<given-names>A. J.</given-names>
</name>
<name>
<surname>Pothineni</surname>
<given-names>N. V. K.</given-names>
</name>
<name>
<surname>Palagiri</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Mehta</surname>
<given-names>J. L.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Oxidative stress in atherosclerosis</article-title>. <source>Curr. Atheroscler. Rep.</source> <volume>19</volume> (<issue>11</issue>), <fpage>42</fpage>. <pub-id pub-id-type="doi">10.1007/s11883-017-0678-6</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaur</surname>
<given-names>I. P.</given-names>
</name>
<name>
<surname>Geetha</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Screening methods for antioxidants-a review</article-title>. <source>Mini Rev. Med. Chem.</source> <volume>6</volume> (<issue>3</issue>), <fpage>305</fpage>&#x2013;<lpage>312</lpage>. <pub-id pub-id-type="doi">10.2174/138955706776073448</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Keaney</surname>
<given-names>J. F.</given-names>
<suffix>Jr.</suffix>
</name>
<name>
<surname>Larson</surname>
<given-names>M. G.</given-names>
</name>
<name>
<surname>Vasan</surname>
<given-names>R. S.</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>P. W.</given-names>
</name>
<name>
<surname>Lipinska</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Corey</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2003</year>). <article-title>Obesity and systemic oxidative stress: Clinical correlates of oxidative stress in the framingham study</article-title>. <source>Arterioscler. Thromb. Vasc. Biol.</source> <volume>23</volume> (<issue>3</issue>), <fpage>434</fpage>&#x2013;<lpage>439</lpage>. <pub-id pub-id-type="doi">10.1161/01.Atv.0000058402.34138.11</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khutami</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Sumiwi</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Khairul Ikram</surname>
<given-names>N. K.</given-names>
</name>
<name>
<surname>Muchtaridi</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>The effects of antioxidants from natural products on obesity, dyslipidemia, diabetes and their molecular signaling mechanism</article-title>. <source>Int. J. Mol. Sci.</source> <volume>23</volume> (<issue>4</issue>), <fpage>2056</fpage>. <pub-id pub-id-type="doi">10.3390/ijms23042056</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kinlay</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Behrendt</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Delagrange</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Morrow</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Witztum</surname>
<given-names>J. L.</given-names>
</name>
<etal/>
</person-group> (<year>2004</year>). <article-title>Long-term effect of combined vitamins E and C on coronary and peripheral endothelial function</article-title>. <source>J. Am. Coll. Cardiol.</source> <volume>43</volume> (<issue>4</issue>), <fpage>629</fpage>&#x2013;<lpage>634</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacc.2003.08.051</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kong</surname>
<given-names>S. Y.</given-names>
</name>
<name>
<surname>Bostick</surname>
<given-names>R. M.</given-names>
</name>
<name>
<surname>Flanders</surname>
<given-names>W. D.</given-names>
</name>
<name>
<surname>McClellan</surname>
<given-names>W. M.</given-names>
</name>
<name>
<surname>Thyagarajan</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Gross</surname>
<given-names>M. D.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Oxidative balance score, colorectal adenoma, and markers of oxidative stress and inflammation</article-title>. <source>Cancer Epidemiol. Biomarkers Prev.</source> <volume>23</volume> (<issue>3</issue>), <fpage>545</fpage>&#x2013;<lpage>554</lpage>. <pub-id pub-id-type="doi">10.1158/1055-9965.Epi-13-0619</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kong</surname>
<given-names>S. Y.</given-names>
</name>
<name>
<surname>Goodman</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Judd</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bostick</surname>
<given-names>R. M.</given-names>
</name>
<name>
<surname>Flanders</surname>
<given-names>W. D.</given-names>
</name>
<name>
<surname>McClellan</surname>
<given-names>W.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Oxidative balance score as predictor of all-cause, cancer, and noncancer mortality in a biracial US cohort</article-title>. <source>Ann. Epidemiol.</source> <volume>25</volume> (<issue>4</issue>), <fpage>256</fpage>&#x2013;<lpage>262.e1</lpage>. <pub-id pub-id-type="doi">10.1016/j.annepidem.2015.01.004</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lakkur</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Goodman</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bostick</surname>
<given-names>R. M.</given-names>
</name>
<name>
<surname>Citronberg</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>McClellan</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Flanders</surname>
<given-names>W. D.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Oxidative balance score and risk for incident prostate cancer in a prospective U.S. cohort study</article-title>. <source>Ann. Epidemiol.</source> <volume>24</volume> (<issue>6</issue>), <fpage>475</fpage>&#x2013;<lpage>478.e4</lpage>. <pub-id pub-id-type="doi">10.1016/j.annepidem.2014.02.015</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lepara</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Zaciragic</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Fajkic</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Dzubur Kulenovic</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Dervisevic</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Valjevac</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Peripheral 8-iso-PGF2&#x3b1; as a biomarker in Bosnian patients with alzheimer&#x27;s disease and vascular dementia</article-title>. <source>Psychiatr. Danub</source> <volume>32</volume> (<issue>3-4</issue>), <fpage>389</fpage>&#x2013;<lpage>394</lpage>. <pub-id pub-id-type="doi">10.24869/psyd.2020.389</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lv</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>J. G.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Angiotensin-converting enzyme gene D/I polymorphism in relation to endothelial function and endothelial-released factors in Chinese women</article-title>. <source>Front. Physiol.</source> <volume>11</volume>, <fpage>951</fpage>. <pub-id pub-id-type="doi">10.3389/fphys.2020.00951</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Milani</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Basirnejad</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Shahbazi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bolhassani</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Carotenoids: Biochemistry, pharmacology and treatment</article-title>. <source>Br. J. Pharmacol.</source> <volume>174</volume> (<issue>11</issue>), <fpage>1290</fpage>&#x2013;<lpage>1324</lpage>. <pub-id pub-id-type="doi">10.1111/bph.13625</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Milne</surname>
<given-names>G. L.</given-names>
</name>
<name>
<surname>Sanchez</surname>
<given-names>S. C.</given-names>
</name>
<name>
<surname>Musiek</surname>
<given-names>E. S.</given-names>
</name>
<name>
<surname>Morrow</surname>
<given-names>J. D.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Quantification of F2-isoprostanes as a biomarker of oxidative stress</article-title>. <source>Nat. Protoc.</source> <volume>2</volume> (<issue>1</issue>), <fpage>221</fpage>&#x2013;<lpage>226</lpage>. <pub-id pub-id-type="doi">10.1038/nprot.2006.375</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morrow</surname>
<given-names>J. D.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans</article-title>. <source>Arterioscler. Thromb. Vasc. Biol.</source> <volume>25</volume> (<issue>2</issue>), <fpage>279</fpage>&#x2013;<lpage>286</lpage>. <pub-id pub-id-type="doi">10.1161/01.ATV.0000152605.64964.c0</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mueller</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Dieplinger</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Gegenhuber</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Haidinger</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Schmid</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Roth</surname>
<given-names>N.</given-names>
</name>
<etal/>
</person-group> (<year>2004</year>). <article-title>Serum total 8-iso-prostaglandin F2alpha: A new and independent predictor of peripheral arterial disease</article-title>. <source>J. Vasc. Surg.</source> <volume>40</volume> (<issue>4</issue>), <fpage>768</fpage>&#x2013;<lpage>773</lpage>. <pub-id pub-id-type="doi">10.1016/j.jvs.2004.07.044</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Niki</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Oxidant-specific biomarkers of oxidative stress. Association with atherosclerosis and implication for antioxidant effects</article-title>. <source>Free Radic. Biol. Med.</source> <volume>120</volume>, <fpage>425</fpage>&#x2013;<lpage>440</lpage>. <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2018.04.001</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Noruzi</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Jayedi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Farazi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Asgari</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Dehghani Firouzabadi</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Akbarzadeh</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Association of oxidative balance score with the metabolic syndrome in a sample of Iranian adults</article-title>. <source>Oxid. Med. Cell Longev.</source> <volume>2021</volume>, <fpage>5593919</fpage>. <pub-id pub-id-type="doi">10.1155/2021/5593919</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nourooz-Zadeh</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Key issues in F2-isoprostane analysis</article-title>. <source>Biochem. Soc. Trans.</source> <volume>36</volume>, <fpage>1060</fpage>&#x2013;<lpage>1065</lpage>. <pub-id pub-id-type="doi">10.1042/bst0361060</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Padayatty</surname>
<given-names>S. J.</given-names>
</name>
<name>
<surname>Katz</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Eck</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Kwon</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J. H.</given-names>
</name>
<etal/>
</person-group> (<year>2003</year>). <article-title>Vitamin C as an antioxidant: Evaluation of its role in disease prevention</article-title>. <source>J. Am. Coll. Nutr.</source> <volume>22</volume> (<issue>1</issue>), <fpage>18</fpage>&#x2013;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1080/07315724.2003.10719272</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pietta</surname>
<given-names>P. G.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Flavonoids as antioxidants</article-title>. <source>J. Nat. Prod.</source> <volume>63</volume> (<issue>7</issue>), <fpage>1035</fpage>&#x2013;<lpage>1042</lpage>. <pub-id pub-id-type="doi">10.1021/np9904509</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qu</surname>
<given-names>N.-n.</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Study on the reliability and validity of international physical activity questionnaire (Chinese Vision, IPAQ)</article-title>. <source>Chin. J. Epidemiol.</source> <volume>25</volume> (<issue>3</issue>), <fpage>265</fpage>&#x2013;<lpage>268</lpage>.</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Radak</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>H. Y.</given-names>
</name>
<name>
<surname>Goto</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Systemic adaptation to oxidative challenge induced by regular exercise</article-title>. <source>Free Radic. Biol. Med.</source> <volume>44</volume> (<issue>2</issue>), <fpage>153</fpage>&#x2013;<lpage>159</lpage>. <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2007.01.029</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rimm</surname>
<given-names>E. B.</given-names>
</name>
<name>
<surname>Stampfer</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Ascherio</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Giovannucci</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Colditz</surname>
<given-names>G. A.</given-names>
</name>
<name>
<surname>Willett</surname>
<given-names>W. C.</given-names>
</name>
</person-group> (<year>1993</year>). <article-title>Vitamin E consumption and the risk of coronary heart disease in men</article-title>. <source>N. Engl. J. Med.</source> <volume>328</volume> (<issue>20</issue>), <fpage>1450</fpage>&#x2013;<lpage>1456</lpage>. <pub-id pub-id-type="doi">10.1056/nejm199305203282004</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodrigo</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Libuy</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Feli&#xfa;</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Hasson</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Oxidative stress-related biomarkers in essential hypertension and ischemia-reperfusion myocardial damage</article-title>. <source>Dis. Markers</source> <volume>35</volume> (<issue>6</issue>), <fpage>773</fpage>&#x2013;<lpage>790</lpage>. <pub-id pub-id-type="doi">10.1155/2013/974358</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schulz</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Gori</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>M&#xfc;nzel</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Oxidative stress and endothelial dysfunction in hypertension</article-title>. <source>Hypertens. Res.</source> <volume>34</volume> (<issue>6</issue>), <fpage>665</fpage>&#x2013;<lpage>673</lpage>. <pub-id pub-id-type="doi">10.1038/hr.2011.39</pub-id>
</citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Snezhkina</surname>
<given-names>A. V.</given-names>
</name>
<name>
<surname>Kudryavtseva</surname>
<given-names>A. V.</given-names>
</name>
<name>
<surname>Kardymon</surname>
<given-names>O. L.</given-names>
</name>
<name>
<surname>Savvateeva</surname>
<given-names>M. V.</given-names>
</name>
<name>
<surname>Melnikova</surname>
<given-names>N. V.</given-names>
</name>
<name>
<surname>Krasnov</surname>
<given-names>G. S.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>ROS generation and antioxidant defense systems in normal and malignant cells</article-title>. <source>Oxid. Med. Cell Longev.</source> <volume>2019</volume>, <fpage>6175804</fpage>. <pub-id pub-id-type="doi">10.1155/2019/6175804</pub-id>
</citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stahl</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Sies</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Antioxidant activity of carotenoids</article-title>. <source>Mol. Asp. Med.</source> <volume>24</volume> (<issue>6</issue>), <fpage>345</fpage>&#x2013;<lpage>351</lpage>. <pub-id pub-id-type="doi">10.1016/s0098-2997(03)00030-x</pub-id>
</citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stanner</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Hughes</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kelly</surname>
<given-names>C. N.</given-names>
</name>
<name>
<surname>Buttriss</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>A review of the epidemiological evidence for the &#x27;antioxidant hypothesis</article-title>. <source>Public Health Nutr.</source> <volume>7</volume> (<issue>3</issue>), <fpage>407</fpage>&#x2013;<lpage>422</lpage>. <pub-id pub-id-type="doi">10.1079/phn2003543</pub-id>
</citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stupin</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kibel</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Stupin</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Selthofer-Relati&#x107;</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Mati&#x107;</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mihalj</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>The physiological effect of n-3 polyunsaturated fatty acids (n-3 PUFAs) intake and exercise on hemorheology, microvascular function, and physical performance in health and cardiovascular diseases; is there an interaction of exercise and dietary n-3 PUFA intake?</article-title> <source>Front. Physiol.</source> <volume>10</volume>, <fpage>1129</fpage>. <pub-id pub-id-type="doi">10.3389/fphys.2019.01129</pub-id>
</citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Syrovatka</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Kraml</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Hulikova</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Fialova</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Vejrazka</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Crkovska</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>Iron stores are associated with asymptomatic atherosclerosis in healthy men of primary prevention</article-title>. <source>Eur. J. Clin. Invest.</source> <volume>41</volume> (<issue>8</issue>), <fpage>846</fpage>&#x2013;<lpage>853</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2362.2011.02474.x</pub-id>
</citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tamimi</surname>
<given-names>R. M.</given-names>
</name>
<name>
<surname>Hankinson</surname>
<given-names>S. E.</given-names>
</name>
<name>
<surname>Campos</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Spiegelman</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Colditz</surname>
<given-names>G. A.</given-names>
</name>
<etal/>
</person-group> (<year>2005</year>). <article-title>Plasma carotenoids, retinol, and tocopherols and risk of breast cancer</article-title>. <source>Am. J. Epidemiol.</source> <volume>161</volume> (<issue>2</issue>), <fpage>153</fpage>&#x2013;<lpage>160</lpage>. <pub-id pub-id-type="doi">10.1093/aje/kwi030</pub-id>
</citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thijssen</surname>
<given-names>D. H.</given-names>
</name>
<name>
<surname>Black</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Pyke</surname>
<given-names>K. E.</given-names>
</name>
<name>
<surname>Padilla</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Atkinson</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Harris</surname>
<given-names>R. A.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>Assessment of flow-mediated dilation in humans: A methodological and physiological guideline</article-title>. <source>Am. J. Physiol. Heart Circ. Physiol.</source> <volume>300</volume> (<issue>1</issue>), <fpage>H2</fpage>&#x2013;<lpage>H12</lpage>. <pub-id pub-id-type="doi">10.1152/ajpheart.00471.2010</pub-id>
</citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thijssen</surname>
<given-names>D. H. J.</given-names>
</name>
<name>
<surname>Bruno</surname>
<given-names>R. M.</given-names>
</name>
<name>
<surname>van Mil</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Holder</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Faita</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Greyling</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Expert consensus and evidence-based recommendations for the assessment of flow-mediated dilation in humans</article-title>. <source>Eur. Heart J.</source> <volume>40</volume> (<issue>30</issue>), <fpage>2534</fpage>&#x2013;<lpage>2547</lpage>. <pub-id pub-id-type="doi">10.1093/eurheartj/ehz350</pub-id>
</citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Toborek</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Barger</surname>
<given-names>S. W.</given-names>
</name>
<name>
<surname>Mattson</surname>
<given-names>M. P.</given-names>
</name>
<name>
<surname>Barve</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>McClain</surname>
<given-names>C. J.</given-names>
</name>
<name>
<surname>Hennig</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>1996</year>). <article-title>Linoleic acid and TNF-alpha cross-amplify oxidative injury and dysfunction of endothelial cells</article-title>. <source>J. Lipid Res.</source> <volume>37</volume> (<issue>1</issue>), <fpage>123</fpage>&#x2013;<lpage>135</lpage>. <pub-id pub-id-type="doi">10.1016/s0022-2275(20)37641-0</pub-id>
</citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Upritchard</surname>
<given-names>J. E.</given-names>
</name>
<name>
<surname>Schuurman</surname>
<given-names>C. R.</given-names>
</name>
<name>
<surname>Wiersma</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Tijburg</surname>
<given-names>L. B.</given-names>
</name>
<name>
<surname>Coolen</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Rijken</surname>
<given-names>P. J.</given-names>
</name>
<etal/>
</person-group> (<year>2003</year>). <article-title>Spread supplemented with moderate doses of vitamin E and carotenoids reduces lipid peroxidation in healthy, nonsmoking adults</article-title>. <source>Am. J. Clin. Nutr.</source> <volume>78</volume> (<issue>5</issue>), <fpage>985</fpage>&#x2013;<lpage>992</lpage>. <pub-id pub-id-type="doi">10.1093/ajcn/78.5.985</pub-id>
</citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Valko</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Leibfritz</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Moncol</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cronin</surname>
<given-names>M. T.</given-names>
</name>
<name>
<surname>Mazur</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Telser</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Free radicals and antioxidants in normal physiological functions and human disease</article-title>. <source>Int. J. Biochem. Cell Biol.</source> <volume>39</volume> (<issue>1</issue>), <fpage>44</fpage>&#x2013;<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1016/j.biocel.2006.07.001</pub-id>
</citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Valko</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Jomova</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Rhodes</surname>
<given-names>C. J.</given-names>
</name>
<name>
<surname>Ku&#x10d;a</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Mus&#xed;lek</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Redox- and non-redox-metal-induced formation of free radicals and their role in human disease</article-title>. <source>Arch. Toxicol.</source> <volume>90</volume> (<issue>1</issue>), <fpage>1</fpage>&#x2013;<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1007/s00204-015-1579-5</pub-id>
</citation>
</ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van Beelen</surname>
<given-names>V. A.</given-names>
</name>
<name>
<surname>Aarts</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Reus</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mooibroek</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Sijtsma</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Bosch</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2006</year>). <article-title>Differential induction of electrophile-responsive element-regulated genes by n-3 and n-6 polyunsaturated fatty acids</article-title>. <source>FEBS Lett.</source> <volume>580</volume> (<issue>19</issue>), <fpage>4587</fpage>&#x2013;<lpage>4590</lpage>. <pub-id pub-id-type="doi">10.1016/j.febslet.2006.07.028</pub-id>
</citation>
</ref>
<ref id="B61">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>van der Vaart</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Postma</surname>
<given-names>D. S.</given-names>
</name>
<name>
<surname>Timens</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>ten Hacken</surname>
<given-names>N. H.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Acute effects of cigarette smoke on inflammation and oxidative stress: A review</article-title>. <source>Thorax</source> <volume>59</volume> (<issue>8</issue>), <fpage>713</fpage>&#x2013;<lpage>721</lpage>. <pub-id pub-id-type="doi">10.1136/thx.2003.012468</pub-id>
</citation>
</ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van Hoydonck</surname>
<given-names>P. G.</given-names>
</name>
<name>
<surname>Temme</surname>
<given-names>E. H.</given-names>
</name>
<name>
<surname>Schouten</surname>
<given-names>E. G.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>A dietary oxidative balance score of vitamin C, beta-carotene and iron intakes and mortality risk in male smoking Belgians</article-title>. <source>J. Nutr.</source> <volume>132</volume> (<issue>4</issue>), <fpage>756</fpage>&#x2013;<lpage>761</lpage>. <pub-id pub-id-type="doi">10.1093/jn/132.4.756</pub-id>
</citation>
</ref>
<ref id="B63">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yimcharoen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kittikunnathum</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Suknikorn</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Nak-On</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Yeethong</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Anthony</surname>
<given-names>T. G.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Effects of ascorbic acid supplementation on oxidative stress markers in healthy women following a single bout of exercise</article-title>. <source>J. Int. Soc. Sports Nutr.</source> <volume>16</volume> (<issue>1</issue>), <fpage>2</fpage>. <pub-id pub-id-type="doi">10.1186/s12970-019-0269-8</pub-id>
</citation>
</ref>
<ref id="B64">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yokoyama</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Oxidant stress and atherosclerosis</article-title>. <source>Curr. Opin. Pharmacol.</source> <volume>4</volume> (<issue>2</issue>), <fpage>110</fpage>&#x2013;<lpage>115</lpage>. <pub-id pub-id-type="doi">10.1016/j.coph.2003.12.004</pub-id>
</citation>
</ref>
<ref id="B65">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yusuf</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Dagenais</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Pogue</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bosch</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sleight</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Vitamin E supplementation and cardiovascular events in high-risk patients</article-title>. <source>N. Engl. J. Med.</source> <volume>342</volume> (<issue>3</issue>), <fpage>154</fpage>&#x2013;<lpage>160</lpage>. <pub-id pub-id-type="doi">10.1056/nejm200001203420302</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>